Abstract 3791: A prognostic signature based on inherited genetic polymorphisms for patients with uveal melanoma

黑色素瘤 医学 癌症 签名(拓扑) 肿瘤科 内科学 癌症研究 几何学 数学
作者
Thibault Verrier,Anne L. van de Ven,Alexandre Houy,Agathe Garcia,Gaëlle Pierron,Nathalie Cassoux,Manuel Rodrigues,Josselin Noirel,Marc‐Henri Stern
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (6_Supplement): 3791-3791
标识
DOI:10.1158/1538-7445.am2024-3791
摘要

Abstract Introduction: Uveal melanoma (UM) is the most frequent eye malignancy in adults. Two UM subtypes exist, defined by Gene Expression Profiling or by genomic status: GEP class 1/disomy 3 [D3] and GEP class 2/monosomy 3 [M3] defining low-risk or high-risk of developing metastasis, respectively. However, these prognostic signatures require tumor samples, which may be difficult to obtain. We previously identified by a genome-wide association study (GWAS) frequent single nucleotide polymorphisms (SNP) in IRF4 and HERC2 associated with risk for D3 or M3 UM, respectively (1). Here, we aim to design a prognostic signature for the D3 and M3 UM subtypes based on these constitutive polymorphisms, available from blood samples. Experimental Procedures: We used the GWAS cohort of 1476 UM patients genotyped on GSA or Omni5. Risk SNPs coupled with clinical variables were used on a cohort of 497 UM patients (191 D3, 306 M3) in a statistical machine learning process to define a predictive signature of UM subtype. A cohort of 852 UM patients was used for validation. Results: We retained two SNPs, rs12203592 (in IRF4) and rs12913832 (in HERC2), tumor diameter and thickness, age at diagnosis and gender. We validated the predictive model in the validation cohort. The predicted high-risk group showed a decrease in time to relapse (TR) (HR: 3.72 [2.57 - 5.41], logrank p-value = 1.35E-15), overall survival (OS) (HR: 3.85 [2.58 - 5.73], logrank p-value = 1.24E-14) and progression-free-survival (PFS) (HR: 3.61 [2.32 - 5.61], logrank p-value = 6.55E-11), compared with the predicted low-risk group. Conclusion: Common germline polymorphisms contribute to the prediction of metastatic risk in patients with localized uveal melanoma. This information could be especially useful when access to the tumor is problematic. 1. Mobuchon et al, J Natl Cancer Inst, 114, 2, (2022) Citation Format: Thibault Verrier, Anaïs Le Ven, Alexandre Houy, Agathe Garcia, Pierron Gaelle, Nathalie Cassoux, Manuel Rodrigues, Josselin Noirel, Marc-Henri Stern. A prognostic signature based on inherited genetic polymorphisms for patients with uveal melanoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 3791.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
奥丁蒂法完成签到,获得积分10
刚刚
刚刚
刚刚
1秒前
1秒前
小李子发布了新的文献求助10
2秒前
小田发布了新的文献求助20
3秒前
4秒前
4秒前
灵巧映安发布了新的文献求助10
5秒前
5秒前
超级小飞侠完成签到,获得积分10
5秒前
量子星尘发布了新的文献求助10
6秒前
踏实威完成签到,获得积分10
6秒前
SciGPT应助zzaxx123采纳,获得10
7秒前
弄香发布了新的文献求助10
9秒前
欣慰的白羊完成签到,获得积分10
10秒前
fanhongpeng完成签到 ,获得积分10
10秒前
10秒前
11秒前
ermiao发布了新的文献求助10
11秒前
小李子完成签到,获得积分10
13秒前
JamesPei应助曙丽盼采纳,获得10
14秒前
无极微光应助隐形的若灵采纳,获得20
14秒前
打打应助种花家的狗狗采纳,获得10
14秒前
善学以致用应助TingtingGZ采纳,获得10
14秒前
Stroeve完成签到,获得积分10
15秒前
lzylzy完成签到,获得积分10
15秒前
16秒前
16秒前
zh完成签到,获得积分10
18秒前
lzylzy发布了新的文献求助10
19秒前
20秒前
李顺利给李顺利的求助进行了留言
21秒前
21秒前
21秒前
22秒前
22秒前
23秒前
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1581
Encyclopedia of Agriculture and Food Systems Third Edition 1500
Specialist Periodical Reports - Organometallic Chemistry Organometallic Chemistry: Volume 46 1000
Handbook of Spirituality, Health, and Well-Being 800
Current Trends in Drug Discovery, Development and Delivery (CTD4-2022) 800
Foregrounding Marking Shift in Sundanese Written Narrative Segments 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5526942
求助须知:如何正确求助?哪些是违规求助? 4616873
关于积分的说明 14556205
捐赠科研通 4555440
什么是DOI,文献DOI怎么找? 2496353
邀请新用户注册赠送积分活动 1476654
关于科研通互助平台的介绍 1448212